Application
Fig1: Western blot analysis of Rab6b on human Rab6b recombinant protein using anti-Rab6b antibody at 1/1,000 dilution.
Application
Fig2: Western blot analysis of Rab6b on HEK293 (1) and Rab6b-hIgGFc transfected HEK293 (2) cell lysate using anti-Rab6b antibody at 1/1,000 dilution.
Application
Fig3: Western blot analysis of Rab6b on different cell lysate using anti-Rab6b antibody at 1/1,000 dilution. Positive control: Lane1: C6 Lane2: HT-29 Lane3: PC-12
Application
Fig4:ICC staining Rab6b (green) and Actin filaments (red) in Hela cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig5: ICC staining Rab6b (green) and Actin filaments (red) in HepG2 cells. The nuclear counter stain is DAPI (blue). Cells were fixed in paraformaldehyde, permeabilised with 0.25% Triton X100/PBS.
Application
Fig6: Immunohistochemical analysis of paraffin-embedded human lung cancer tissue using anti-Rab6b antibody. Counter stained with hematoxylin.
Application
Fig7: Immunohistochemical analysis of paraffin-embedded human ovarian cancer tissue using anti-Rab6b antibody. Counter stained with hematoxylin.
Application
Fig8:Flow cytometric analysis of Hela cells with Rab6b antibody at 1/100 dilution (green) compared with an unlabelled control (cells without incubation with primary antibody; red).